As of January 22, 2025, Agenus (AGEN) has a market cap of $86.420 million USD. According to our data, Agenus is ranked No.7796 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $86.42 M |
33.58%
|
Dec 31, 2024 | $64.70 M |
-83.49%
|
Dec 29, 2023 | $0.39 B |
-64.76%
|
Dec 30, 2022 | $1.11 B |
-25.47%
|
Dec 31, 2021 | $1.49 B |
1.26%
|
Dec 31, 2020 | $1.47 B |
-21.87%
|
Dec 31, 2019 | $1.89 B |
71.01%
|
Dec 31, 2018 | $1.10 B |
-26.99%
|
Dec 29, 2017 | $1.51 B |
-20.87%
|
Dec 30, 2016 | $1.91 B |
-9.25%
|
Dec 31, 2015 | $2.10 B |
14.36%
|
Dec 31, 2014 | $1.84 B |
50.38%
|
Dec 31, 2013 | $1.22 B |
-35.61%
|
Dec 31, 2012 | $1.90 B |
105.00%
|
Dec 30, 2011 | $0.93 B |
-67.00%
|
Dec 31, 2010 | $2.81 B |
57.81%
|
Dec 31, 2009 | $1.78 B |
33.33%
|
Dec 31, 2008 | $1.33 B |
-76.47%
|
Dec 31, 2007 | $5.67 B |
11.48%
|
Dec 29, 2006 | $5.09 B |
-61.55%
|
Dec 30, 2005 | $13.24 B |
-52.96%
|
Dec 31, 2004 | $28.14 B |
-10.76%
|
Dec 31, 2003 | $31.53 B |
10.74%
|
Dec 31, 2002 | $28.47 B |
-37.56%
|
Dec 31, 2001 | $45.60 B |
48.25%
|
Dec 29, 2000 | $30.76 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Avangrid
AGR
|
$13.94 B |
0.000 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Market Cap | = | AGEN Stock Price | * | AGEN Shares Outstanding |
= | $3.66 | * | 23.61 M | |
= | $86.42 M |